BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35682709)

  • 21. The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.
    Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.
    Du H; Chen Y; Hou X; Huang Y; Wei X; Yu X; Feng S; Wu Y; Zhan M; Shi X; Lin S; Lu L; Yuan S; Sun L
    Cell Death Dis; 2017 Oct; 8(10):e3143. PubMed ID: 29072684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Upregulation of PLOD2 promotes invasion and metastasis of osteosarcoma cells].
    Cao F; Kang XH; Cui YH; Wang Y; Zhao KL; Wang YN; Kou WZ; Miao ZH; Cao XJ
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):435-440. PubMed ID: 31216829
    [No Abstract]   [Full Text] [Related]  

  • 25. PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway.
    Lan J; Zhang S; Zheng L; Long X; Chen J; Liu X; Zhou M; Zhou J
    Cancer Sci; 2023 Aug; 114(8):3190-3202. PubMed ID: 37227305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma.
    Dumitru CA; Schröder H; Schäfer FTA; Aust JF; Kreße N; Siebert CLR; Stein KP; Haghikia A; Wilkens L; Mawrin C; Sandalcioglu IE
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling.
    Wang Z; Shi Y; Ying C; Jiang Y; Hu J
    Oncogene; 2021 Feb; 40(8):1458-1475. PubMed ID: 33420370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic significance of TCTN1 in human glioblastoma.
    Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
    J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma.
    Dumitru CA; Brouwer E; Stelzer T; Nocerino S; Rading S; Wilkens L; Sandalcioglu IE; Karsak M
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of microRNA-124 in biological behaviors of laryngeal carcinoma via PLOD2 signaling pathway.
    Huang J; Zhou XH; Huang S; Li S; Wu TT
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4855-4862. PubMed ID: 32432748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT6 expression in glioblastoma promotes invasive growth.
    Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
    BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1.
    Rosell-García T; Palomo-Álvarez O; Rodríguez-Pascual F
    J Biol Chem; 2019 Sep; 294(39):14308-14318. PubMed ID: 31391253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
    J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
    Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
    Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apelin promotes osteosarcoma metastasis by upregulating PLOD2 expression via the Hippo signaling pathway and hsa_circ_0000004/miR-1303 axis.
    Trang NTN; Lai CY; Tsai HC; Huang YL; Liu SC; Tsai CH; Fong YC; Tzeng HE; Tang CH
    Int J Biol Sci; 2023; 19(2):412-425. PubMed ID: 36632453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.